Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Migalastat in Fabry Disease (> 12 years)
NCT04049760Phase 3Completed
- Sponsor
- Amicus Therapeutics
- Start
- Oct 2019
- Primary completion
- Nov 2024
- Countries
- 2
01
Overview
A Phase 3 trial of migalastat in Fabry disease (FD), sponsored by Amicus Therapeutics. Started Oct 2019; status: completed.
02
Drugs
migalastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT04049760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04049760.